Investigating the main risk factor for sporadic AD, our meta‐analysis demonstrated an association between APOE ε4 carriership and lower cognitive resilience, as well as a significant role of APOE ε4 in moderating the relationship between brain pathology and cognition (albeit not surviving multiple testing correction). Here, APOE is linked to Alzheimer disease.